Figures computed from official regulatory filings — .
Analysttarget 38.79 USD (+268%) · consensus 4.29/5 · 6 buy · 0 hold · 1 sell
Ownershipinsiders 0% · institutions 41.66% · short 2.2% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for DBV Technologies S.A. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
4 buys19 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Mohideen Pharis | Sell | $1.3K | SEC |
| Mohideen Pharis | Sell | $2.6K | SEC |
| BAKER JULIANtrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| BAKER JULIANtrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| BAKER JULIANtrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| BAKER JULIANtrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| EPIC Bpifrance | Sell | $211.2K | SEC |
| EPIC Bpifrance | Sell | $5.4M | SEC |
| EPIC Bpifrance | Sell | $9.9M | SEC |
| Mohideen Pharis | Sell | $18.7K | Unusual size | SEC |
| Mohideen Pharis | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mohideen Pharis | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mohideen Pharis | Sell | $4.5K | SEC |
| Boucinha Virginie | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Trapp Kevin Michael | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Boucinha Virginie | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Trapp Kevin Michael | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Tasse Daniel | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mohideen Pharis | Sell | $1K | SEC |
| Mohideen Pharis | Sell | $730.5 | SEC |
| Baker Brothers Life Sciences LPtrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Baker Brothers Life Sciences LPtrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Baker Brothers Life Sciences LPtrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Baker Brothers Life Sciences LPtrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Mohideen Pharis | Sell | $510 | SEC |